CNTB
Connect Biopharma Holdings LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$157.13M
P/E Ratio
—
EPS
$-1.00
Beta
-0.18
52W High
$3.82
52W Low
$0.63
50-Day MA
$2.71
200-Day MA
$2.13
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.77
PEG Ratio
—
About Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe autoimmune diseases and inflammation. The company is headquartered in Taicang, China.
Fundamentals
| Revenue (TTM) | 64,000 |
| Gross Profit (TTM) | 64,000 |
| EBITDA | $-57.37M |
| Operating Margin | -90741.00% |
| Return on Equity | -82.70% |
| Return on Assets | -46.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.74 |
| Price-to-Book | 3.98 |
| Price-to-Sales (TTM) | 2455.14 |
| EV/Revenue | 1929.68 |
| EV/EBITDA | 0.19 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $56.52M |
| Float | $12.03M |
| % Insiders | 38.06% |
| % Institutions | 50.82% |
Historical Volatility
HV 10-Day
143.13%
HV 20-Day
116.32%
HV 30-Day
101.31%
HV 60-Day
96.03%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($7.90 target)
5
BuyData last updated: 4/10/2026